Literature DB >> 21543484

Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection.

Jane E Libbey1, Nikki J Kennett, Karen S Wilcox, H Steve White, Robert S Fujinami.   

Abstract

Cells that can participate in an innate immune response within the central nervous system (CNS) include infiltrating cells (polymorphonuclear leukocytes [PMNs], macrophages, and natural killer [NK] cells) and resident cells (microglia and sometimes astrocytes). The proinflammatory cytokine interleukin-6 (IL-6) is produced by all of these cells and has been implicated in the development of behavioral seizures in the Theiler's murine encephalomyelitis virus (TMEV)-induced seizure model. The assessment, via PCR arrays, of the mRNA expression levels of a large number of chemokines (ligands and receptors) in TMEV-infected and mock-infected C57BL/6 mice both with and without seizures did not clearly demonstrate the involvement of PMNs, monocytes/macrophages, or NK cells in the development of seizures, possibly due to overlapping function of the chemokines. Additionally, C57BL/6 mice unable to recruit or depleted of infiltrating PMNs and NK cells had seizure rates comparable to those of controls following TMEV infection, and therefore PMNs and NK cells do not significantly contribute to seizure development. In contrast, C57BL/6 mice treated with minocycline, which affects monocytes/macrophages, microglial cells, and PMNs, had significantly fewer seizures than controls following TMEV infection, indicating monocytes/macrophages and resident microglial cells are important in seizure development. Irradiated bone marrow chimeric mice that were either IL-6-deficient mice reconstituted with wild-type bone marrow cells or wild-type mice reconstituted with IL-6-deficient bone marrow cells developed significantly fewer behavioral seizures following TMEV infection. Therefore, both resident CNS cells and infiltrating cells are necessary for seizure development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543484      PMCID: PMC3126579          DOI: 10.1128/JVI.00458-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Induction of interleukin-6 by depolarization of neurons.

Authors:  S Sallmann; E Jüttler; S Prinz; N Petersen; U Knopf; T Weiser; M Schwaninger
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

2.  Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis.

Authors:  P D Murray; K Krivacic; A Chernosky; T Wei; R M Ransohoff; M Rodriguez
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

3.  Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.

Authors:  I Tsunoda; Y Wada; J E Libbey; T S Cannon; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.

Authors:  Eugene D Ponomarev; Leah P Shriver; Katarzyna Maresz; Bonnie N Dittel
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

5.  Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo.

Authors:  Eva Szomolanyi-Tsuda; Xueya Liang; Raymond M Welsh; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Theiler's virus infection chronically alters seizure susceptibility.

Authors:  Kerry-Ann A Stewart; Karen S Wilcox; Robert S Fujinami; H Steve White
Journal:  Epilepsia       Date:  2009-12-01       Impact factor: 5.864

7.  Effects of antibiotics on human polymorphonuclear leukocyte chemotaxis in vitro.

Authors:  Y Ueyama; M Misaki; Y Ishihara; T Matsumura
Journal:  Br J Oral Maxillofac Surg       Date:  1994-04       Impact factor: 1.651

Review 8.  Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness.

Authors:  Joanna Mika
Journal:  Pharmacol Rep       Date:  2008 May-Jun       Impact factor: 3.024

9.  Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages.

Authors:  J Jensen; T Warner; E Balish
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

10.  The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease.

Authors:  Thaddeus Carlson; Mark Kroenke; Praveen Rao; Thomas E Lane; Benjamin Segal
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

View more
  61 in total

Review 1.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

2.  A swell in the armamentarium of antiepileptic drug targets.

Authors:  Karthik Rajasekaran; Howard Parker Goodkin
Journal:  Epilepsy Curr       Date:  2011-11       Impact factor: 7.500

3.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

4.  Once initiated, viral encephalitis-induced seizures are consistent no matter the treatment or lack of interleukin-6.

Authors:  Jane E Libbey; Nikki J Kennett; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Neurovirol       Date:  2011-08-11       Impact factor: 2.643

Review 5.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

6.  Decrease in CA3 inhibitory network activity during Theiler's virus encephalitis.

Authors:  R M Smeal; R Fujinami; H S White; K S Wilcox
Journal:  Neurosci Lett       Date:  2015-10-23       Impact factor: 3.046

7.  Complement Components Are Expressed by Infiltrating Macrophages/Activated Microglia Early Following Viral Infection.

Authors:  Jane E Libbey; Matthew F Cusick; Daniel J Doty; Robert S Fujinami
Journal:  Viral Immunol       Date:  2017-04-12       Impact factor: 2.257

Review 8.  Neuroimmune interaction in seizures and epilepsy: focusing on monocyte infiltration.

Authors:  Dale B Bosco; Dai-Shi Tian; Long-Jun Wu
Journal:  FEBS J       Date:  2020-06-15       Impact factor: 5.542

9.  Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection.

Authors:  Jane E Libbey; Nikki J Kennett; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

Review 10.  Disease modification in epilepsy: from animal models to clinical applications.

Authors:  Melissa L Barker-Haliski; Dan Friedman; Jacqueline A French; H Steve White
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.